Guangzhou Weiaokang Pharmaceutical Technology Co., Ltd Company Information
Company Name:
Guangzhou Weiaokang Pharmaceutical Technology Co., Ltd
Tel:
-
Email:
pengguizi@cti-cert.com
Nationality:
China
WebSite:
Product List:
155
1
2
Product List
Dexpanthenol Impurity3
ETHYL 4-METHOXYBENZOYLACETATE; PhEur/USP(DMF)
2881-83-6
Olaparib; PhEur/USP(DMF)
763113-22-0
Ruxolitinib; PhEur/USP(DMF)
941678-49-5
Trametinib Impurity 13
871700-32-2
Osimertinib; PhEur/USP(DMF)
1421373-65-0
Baricitinib Impurity 4
Baricitinib Impurity 7
Trametinib Impurity 20
871701-23-4
Trametinib Impurity 17
871700-65-1
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one; PhEur/USP(DMF)
6969-71-7
Quisinostat Impurity7
Quisinostat Impurity5
Quisinostat Impurity8
Crizotinib; PhEur/USP(DMF)
877399-52-5
Trametinib Impurity 11
871700-25-3
Avibactam INT 1; PhEur/USP(DMF)
1416134-48-9
1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride; PhEur/USP(DMF)
52605-52-4
Baricitinib Impurity 1
Trametinib Impurity 16
Trametinib Impurity 18
Trametinib Impurity 19
3018911-27-5
Atrasentan Impurity 24
Trametinib Impurity 06
Sunitinib Malate; PhEur/USP(DMF)
341031-54-7
Erlotinib hydrochloride; PhEur/USP(DMF)
183319-69-9
Trametinib Impurity 21
871701-87-0
Methylene Blue; PhEur/USP(DMF)
61-73-4
2-(3-bromo-4,5-dimethoxyphenyl)ethan-1-amine hydrochloride; PhEur/USP(DMF)
92015-18-4
Ethyl 4-(ethoxycarbonyl)piperidine-1-acetate
1838-39-7
Atrasentan Impurity 19
Quisinostat Impurity2
Atrasentan Impurity 18
Pomalidomide; PhEur/USP(DMF)
19171-19-8
Trazodone hydrochloride; PhEur/USP(DMF)
25332-39-2
5-BROMOVERATRALDEHYDE; PhEur/USP(DMF)
6948-30-7
Baricitinib Impurity 5
Methylene Blue trihydrate; PhEur/USP(DMF)
7220-79-3
Dexpanthenol Impurity1
LenalidoMide; PhEur/USP(DMF)
191732-72-6
Trametinib Impurity 10
Atrasentan Impurity 21
Trametinib Impurity 07
Quisinostat Impurity6
4-chloro-7-{[2-(trimethylsilyl)ethoxy]methyl}-7H-pyrrolo[2,3-d]pyrimidine; PhEur/USP(DMF)
941685-26-3
Trametinib Impurity 02
871700-28-6
Trametinib Impurity 12
871700-24-2
lenvatinib Mesylate; PhEur/USP(DMF)
857890-39-2
tert-butyl 4-((1R,2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate; PhEur/USP(DMF)
1174020-63-3
1,3-Benzodioxole,5-[(1E)-2-nitroethenyl]-; PhEur/USP(DMF)
22568-48-5
Baricitinib Impurity 2
Dasatinib; PhEur/USP(DMF)
302962-49-8
Atrasentan Impurity 26
Trametinib Impurity 08
Trametinib Impurity 03
871700-30-0
(2S,3S,4R)-ethyl 4-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate; PhEur/USP(DMF)
173937-93-4
2-(1-(ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile; PhEur/USP(DMF)
1187594-13-3
Aceclidine hydrochloride; PhEur/USP(DMF)
6109-70-2
3-Quinuclidinone hydrochloride; PhEur/USP(DMF)
1193-65-3
3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-2-(4-methoxyphenyl)-, (2R,3R,4S)-, (αS)-α-hydroxybenzeneacetate (9CI); PhEur/USP(DMF)
195529-63-6
(R)-(+)-Verapamilic Acid; PhEur/USP(DMF)
38175-99-4
Trametinib Impurity 04
Atrasentan Impurity 20
Atrasentan Impurity 28
Alectinib; PhEur/USP(DMF)
1256580-46-7
2-[1-(ethylsulfonyl)azetidin-3-ylidene]acetonitrile; PhEur/USP(DMF)
1187595-85-2
(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl sulfate; PhEur/USP(DMF)
1174020-64-4
Methylene blue ; PhEur/USP(DMF)
122965-43-9
Imatinib mesylate; PhEur/USP(DMF)
220127-57-1
Atrasentan Impurity 23
Quisinostat Impurity3
1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole; PhEur/USP(DMF)
1029716-44-6
tert-butyl 4-((2S,5R)-5-(benzyloxyamino)piperidine-2-carboxamido)piperidine-1-carboxylate 4-methylbenzenesulfonate; PhEur/USP(DMF)
1510832-19-5
Trametinib Impurity 15
329941-39-1
Trans-5-(Benzyloxyamino)piperidine-2-carboxylic acid; PhEur/USP(DMF)
1501980-29-5
Baricitinib Impurity 3
Baricitinib Impurity 6
Papaverine hydrochloride; PhEur/USP(DMF)
61-25-6
N-(3,4-dimethoxyphenethyl)-2-(3,4-dimethoxyphenyl)acetamide; PhEur/USP(DMF)
139-76-4
Trametinib Impurity 14
Atrasentan Impurity 27
Quisinostat Impurity4
Atrasentan hydrochloride; PhEur/USP(DMF)
195733-43-8
Dexpanthenol Impurity2
Ceritinib (LDK378); PhEur/USP(DMF)
1032900-25-6
N,N-dibutyl-2-chloro-Acetamide; PhEur/USP(DMF)
2567-59-1
3-(2-Aminoethyl)benzoic acid methyl ester HCl; PhEur/USP(DMF)
167846-36-8
1-(3,4-dimethoxybenzyl)-3,4-dihydro-6,7-dimethoxyisoquinolinium chloride; PhEur/USP(DMF)
5884-22-0
atrasentan; PhEur/USP(DMF)
173937-91-2
(S)-(-)-Verapamilic Acid; PhEur/USP(DMF)
36622-24-9
Atrasentan Impurity 25
Quisinostat Impurity1
Atrasentan Impurity 22
Trametinib Impurity 01
Sorafenib tosylate; PhEur/USP(DMF)
475207-59-1
Tofacitinib citrate; PhEur/USP(DMF)
540737-29-9
GSK1120212 (DMSO solvate); PhEur/USP(DMF)
1187431-43-1
ethyl 3-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxybenzoyl)-4-nitrobutanoate; PhEur/USP(DMF)
173864-45-4
Nilotinib Hydrochloride; PhEur/USP(DMF)
923288-95-3
methyl (2R,3R,4S)-4-(benzo[d][1,3]dioxol-5-yl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate; PhEur/USP(DMF)
250583-09-6
1
2
Copyright 2007© ChemicalBook. All rights reserved.